{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:17:28Z","timestamp":1790389048787,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.vaccine.2016.12.019","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T16:15:43Z","timestamp":1482509743000},"page":"544-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0023-3985","authenticated-orcid":false,"given":"A.","family":"Camacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Eggo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Goeyvaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vandebosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Kucharski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vangeneugden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"Edmunds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.12.019_b0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1414992","article-title":"West African Ebola epidemic after one year\u2013slowing but not yet under control","volume":"372","author":"Agua-Agum","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.12.019_b0010","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1473-3099(14)70995-8","article-title":"Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis","volume":"14","author":"Lewnard","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.019_b0015","doi-asserted-by":"crossref","unstructured":"Camacho A, Kucharski A, Aki-Sawyerr Y, White MA, Flasche S, Baguelin M, et al. Temporal changes in ebola transmission in sierra leone and implications for control requirements: a real-time modelling study. PLoS curr; 2015. p. 7. http:\/\/dx.doi.org\/10.1371\/currents.outbreaks.406ae55e83ec0b5193e30856b9235ed2.","DOI":"10.1371\/currents.outbreaks.406ae55e83ec0b5193e30856b9235ed2"},{"key":"10.1016\/j.vaccine.2016.12.019_b0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMoa1411100","article-title":"Ebola virus disease in West Africa \u2014 the first 9 months of the epidemic and forward projections","volume":"371","author":"WHO Ebola Response Team","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.12.019_b0025","doi-asserted-by":"crossref","first-page":"e009346","DOI":"10.1136\/bmjopen-2015-009346","article-title":"Estimating the probability of demonstrating vaccine efficacy in the declining Ebola epidemic: a Bayesian modelling approach","volume":"5","author":"Camacho","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2016.12.019_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.epidem.2014.09.003","article-title":"Potential for large outbreaks of Ebola virus disease","author":"Camacho","year":"2014","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2016.12.019_b0035","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1073\/pnas.1508814112","article-title":"Measuring the impact of Ebola control measures in Sierra Leone","volume":"112","author":"Kucharski","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.12.019_b0040","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.12.019_b0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1740774515621059","article-title":"Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: statistical considerations, design rationale, and challenges","volume":"13","author":"Vandebosch","year":"2016","journal-title":"Clin Trials"},{"key":"10.1016\/j.vaccine.2016.12.019_b0050","unstructured":"World Health Organisation. Ebola situation reports, n.d. <http:\/\/apps.who.int\/ebola\/ebola-situation-reports> (accessed June 7, 2015)."},{"key":"10.1016\/j.vaccine.2016.12.019_b0055","unstructured":"Leone R of S. Ministry of health and sanitation, n.d. <http:\/\/health.gov.sl\/?page_id=583>."},{"key":"10.1016\/j.vaccine.2016.12.019_b0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1473-3099(15)70139-8","article-title":"Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis","volume":"15","author":"Bellan","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.019_b0065","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia ankara-vectored Ebola vaccines: a randomized clinical trial","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.12.019_b0070","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1017\/S0950268806007217","article-title":"Understanding the dynamics of Ebola epidemics","volume":"135","author":"Legrand","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.12.019_b0075","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1073\/pnas.1518587113","article-title":"Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone","volume":"113","author":"Fang","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2016.12.019_b0080","unstructured":"Nielsen CF, Kidd S, Sillah AR, Davis E, Mermin J, Kilmarx PH. Improving burial practices and cemetery management during an ebola virus disease epidemic \u2014 Sierra Leone, 2014. MMWR, vol. 64; 2015. p. 20\u20137."},{"key":"10.1016\/j.vaccine.2016.12.019_b0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.epidem.2014.12.002","article-title":"Seven challenges for model-driven data collection in experimental and observational studies","volume":"10","author":"Lessler","year":"2015","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2016.12.019_b0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/S0950268811000392","article-title":"Optimal design of studies of influenza transmission in households. I: Case-ascertained studies","volume":"140","author":"Klick","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.12.019_b0095","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1017\/S0950268813001623","article-title":"Optimal design of studies of influenza transmission in households. II: comparison between cohort and case-ascertained studies","volume":"142","author":"Klick","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.12.019_b0100","doi-asserted-by":"crossref","first-page":"e84511","DOI":"10.1371\/journal.pone.0084511","article-title":"HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model","volume":"9","author":"Cori","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.12.019_b0105","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1098\/rsta.2008.0044","article-title":"Estimation of vaccine efficacy in a repeated measures study under heterogeneity of exposure or susceptibility to infection","volume":"366","author":"Valim","year":"2008","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"10.1016\/j.vaccine.2016.12.019_b0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1475-2875-9-82","article-title":"Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials","volume":"9","author":"White","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2016.12.019_b0115","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2011.03.026","article-title":"Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths","volume":"29","author":"Alexander","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.019_b0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jtbi.2013.11.011","article-title":"Bayesian modelling of hunting data may improve the understanding of host-parasite systems: wild boar diseases and vaccination as an example","volume":"343","author":"Calenge","year":"2014","journal-title":"J Theor Biol"},{"key":"10.1016\/j.vaccine.2016.12.019_b0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.epidem.2014.08.003","article-title":"Timing of bacterial carriage sampling in vaccine trials: a modelling study","volume":"9","author":"Scott","year":"2014","journal-title":"Epidemics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T12:26:10Z","timestamp":1536150370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16312269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0264410X16312269"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}